Xiaotong Li

Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China, China (People's Republic)

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-289) Drug-induced Liver Injury Associated with Lopinavir-ritonavir in Patients with COVID-19: A Disproportionality Analysis of U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) Data